Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease

Pediatric Infectious Disease Journal

Volumn 33, Issue 11, 2014, Pages e305-e309

  Liu, Pengbo ^a   Wang, Xiaoqin ^b   Lee, Joong Chul ^a   Teunis, Peter ^c   Hu, Senke ^b   Paradise, Helen Tang ^d   Moe, Christine ^a  

^a EMORY UNIVERSITY   (United States)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diarrhea; FUt2; Genotype; Norovirus; Secretor

Indexed keywords

FUCOSYLTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; IMMUNOGLOBULIN G;

ACUTE DIARRHEA; ACUTE GASTROENTERITIS; ARTICLE; BLOOD ANALYSIS; CHILD; CHINA; CHINESE; FECES ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NOROVIRUS; NOROVIRUS GII.3; NOROVIRUS GII.4; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CALICIVIRUS INFECTION; DIARRHEA; FECES; GASTROENTERITIS; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; IMMUNOLOGY; MICROBIOLOGY; PRESCHOOL CHILD; VIROLOGY;

ANTIBODIES, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; CALICIVIRIDAE INFECTIONS; CHILD, PRESCHOOL; CHINA; DIARRHEA; FECES; FUCOSYLTRANSFERASES; GASTROENTERITIS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN G; INFANT; MUTATION, MISSENSE; NOROVIRUS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84926074575     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000443     Document Type: Article

References (36)

1. Payne DC, Vinjé J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.s. children. N Engl J Med. 2013;368:1121-1130.
2. hemming M, Räsänen S, Huhti L, et al. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of Rotateq vaccine into the national immunization Programme in Finland. Eur J Pediatr. 2013;172:739-746.
3. Bucardo F, Lindgren PE, Svensson L, et al. Low prevalence of rotavirus and high prevalence of norovirus in hospital and community wastewater after introduction of rotavirus vaccine in Nicaragua. PLoS One. 2011;6:e25962.
4. Xi IN, Graham DY, Wang KN, et al. Norwalk virus genome cloning and characterization. Science. 1990;250:1580-1583.
5. Jiang X, Wang M, Graham DY, et al. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 1992;66:6527-6532.
6. Parker SP, Cubitt WD, Jiang X. Enzyme immunoassay using baculovirus-expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK. J Med Virol. 1995;46:194-200.
7. Smit TK, Bos P, Peenze I, et al. Seroepidemiological study of genogroup I and II calicivirus infections in South and southern Africa. J Med Virol. 1999;59:227-231.
8. Dimitrov DH, Dashti SA, Ball JM, et al. Prevalence of antibodies to human caliciviruses (HuCVs) in Kuwait established by ELISA using baculovirus-expressed capsid antigens representing two genogroups of HuCVs. J Med Virol. 1997;51:115-118.
9. Nurminen K, Blazevic Y Huhti L, et al. Prevalence of norovirus GII-4 antibodies in Finnish children. J Med Virol. 2011;83:525-531.
10. Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011;365: 2178-2187.
11. Zheng DP, Ando T, Fankhauser RL, et al. Norovirus classification and proposed strain nomenclature. Virology. 2006;346:312-323.
12. Jin M, Xie HP, Duan ZJ, et al. Emergence of the GII4/2006b variant and recombinant noroviruses in China. JMedVirol. 2008;80:1997-2004.
13. Iritani N, Kaida A, Abe N, et al. Increase of GII.2 norovirus infections during the 2009-2010 season in Osaka City, Japan. J Med Virol. 2012;84: 517-525.
14. Bruggink LD, Marshall JA. Molecular and epidemiological features of Glib norovirus outbreaks in Victoria, Australia, 2002-2005. J Med Virol. 2009;81:1652-1660.
15. Parrino TA, Schreiber DS, Trier JS, et al. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med. 1977;297:86-89.
16. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003;9:548-553.
17. Chang JG, Yang TY, Liu TC, et al. Molecular analysis of secretor type alpha(1,2)-fucosytransferase gene mutations in the Chinese and Thai populations. Transfusion. 1999;39:1013-1017.
18. Yip SP, Lai SK, Wong ML. Systematic sequence analysis of the human fucosytransferase 2 (FUT2) gene identifies novel sequence variations and alleles. Transfusion. 2007;47:1369-1380.
19. Lindesmith L, Moe C, Lependu J, et al. Cellular and humoral immunity following Snow Mountain virus challenge. J Virol. 2005;79:2900-2909.
20. Rockx BH, Vennema H, Hoebe CJ, et al. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis. 2005;191:749-754.
21. Nordgren J, Kindberg E, Lindgren PE, et al. Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg Infect Dis. 2010;16:81-87.
22. Frenck R, Bernstein DI, Xia M, et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis. 2012;206:1386-1393.
23. Jin M, He Y, Li H, et al. Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes. PLoS One. 2013;8:e58605.
24. Liu P, Hsiao HM, Jaykus LA, et al. Quantification of Norwalk virus inocula: comparison of endpoint titration and real-time reverse transcription-PCR methods. JMedVirol. 2010;82:1612-1616.
25. Kageyama T, Kojima S, Shinohara M, et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol. 2003;41:1548-1557.
26. Dey SK, Nguyen TA, Phan TG, et al. Molecular and epidemiological trend of norovirus associated gastroenteritis in Dhaka City, Bangladesh. J Clin Virol. 2007;40:218-223.
27. Hutson AM, Airaud F, LePendu J, et al. Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol. 2005;77:116-120.
28. Smit TK, Steele AD, Peenze I, et al. Study of Norwalk virus and Mexico virus infections at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa. J Clin Microbiol. 1997;35:2381-2385.
29. O'Ryan ML, Vial PA, Mamani N, et al. Seroprevalence of Norwalk virus and Mexico virus in Chilean individuals: assessment of independent risk factors for antibody acquisition. Clin Infect Dis. 1998;27:789-795.
30. Jing Y, Qian Y, Huo Y, et al. Seroprevalence against Norwalk-like human caliciviruses in Beijing, China. J Med Virol. 2000;60:97-101.
31. Iritani N, Seto T, Hattori H, et al. Humoral immune responses against norovirus infections of children. J Med Virol. 2007;79:1187-1193.
32. Erdman DD, Gary GW, Anderson LJ. Serum immunoglobulin A response to Norwalk virus infection. J Clin Microbiol. 1989;27:1417-1418.
33. Huang P, Farkas T, Zhong W, et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol. 2005;79:6714-6722.
34. Lindesmith LC, Donaldson EF, Lobue AD, et al. Mechanism of GII.4 norovirus persistence in human populations. PLoS Med. 2008;5:269-290
35. Tan M, Jin M, Xie H, et al. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. JMedVirol. 2008;80:1296-1301.
36. Nordgren J, Nitiema LW, Ouermi D, et al. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS One. 2013;8:e69557.